Overview

Update
Status
Acquired by on May 29, 2013
Total Equity Funding
$20.5M in 1 Round from 2 Investors
Headquarters:
Basel, Basel-Stadt
Description:
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Founders:
, , ,
Categories:
Biopharma, Biotechnology, Medical
Website:
http://www.okairos.com

Company Details

Update

Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy.

The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.

Funding Rounds (1) - $20.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2010$20.5M / Series B2

Investors (2)

Current Team (4)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • HQ

    Elisabethenstrasse 3

    Basel, Basel-Stadt CH 4051

    Switzerland

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos